Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCLC | P48506 | 1/20 | 0.50 |
| ▸ | GLUL | P15104 | 1/20 | 0.47 |
| ▸ | GRM8 | O00222 | 2/20 | 0.46 |
| ▸ | GRM6 | O15303 | 2/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.46 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25703220 | 1.00 | GCLC (0.50) | GCLCGLULGRM8GRM6GRM4 | |
| Hydrochloric Acid SCHEMBL8459751 | 0.98 | GCLC (0.49) | GCLCGLULGRM8GRM6GRM4 | |
| SCHEMBL23660119 | 0.84 | CYP2D6 (0.41) | GCLCGLUL | |
| SCHEMBL22216459 | 0.81 | GLUL (0.50) | GCLCGLULGRM8GRM6GRM4 | |
| SCHEMBL9219249 | 0.81 | GLUL (0.44) | GCLCGLULGRM8GRM6GRM4 | |
| SCHEMBL15160608 | 0.80 | GABRR1 (0.41) | — | |
| SCHEMBL28232738 | 0.79 | GCLC (0.47) | GCLCGLULGRM8GRM6GRM4 | |
| SCHEMBL9099903 | 0.79 | GLUL (0.47) | GCLCGLULGRM8GRM6GRM4 | |
| SCHEMBL2322125 | 0.77 | PPARD (0.46) | GCLCGLULGRM8GRM6GRM4 | |
| Glufosinate SCHEMBL28163644 | 0.77 | GCLC (0.46) | GCLCGLULGRM8GRM6GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170247399-A1 | PROCESS OF PRODUCING PHOSPHINOTHRICIN EMPLOYING NITRILASES | STRATEGIC ENZYME APPLICATIONS, INC. (US) | 2017-08-31 | — | — | US | disclosed |
| US-9683001-B2 | Process of producing phosphinothricin employing nitrilases | Stragegic Enzyme Applications, Inc. (US) | 2017-06-20 | — | — | US | disclosed |
| US-9683001-B2 | Process of producing phosphinothricin employing nitrilases | Stragegic Enzyme Applications, Inc. (US) | 2017-06-20 | — | — | US | disclosed |
| US-20150239917-A1 | Process of Producing Phosphinothricin Employing Nitrilases | STRATEGIC ENZYME APPLICATIONS, INC. (US) | 2015-08-27 | — | — | US | disclosed |
| US-8981142-B2 | Process of producing phosphinothricin employing nitrilases | STRATEGIC ENZYME APPLICATIONS, INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-20130204031-A1 | PROCESS OF PRODUCING PHOSPHINOTHRICIN EMPLOYING NITRILASES | STRATEGIC ENZYME APPLICATIONS, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| EP-0358428-B1 | Process for producing optically active compounds | NISSAN CHEMICAL IND LTD (JP) | 1995-04-26 | — | — | EP | disclosed |
| US-5081024-A | Resolution by microbial fermentation | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1992-01-14 | — | — | US | disclosed |
| EP-0358428-A2 | Process for producing optically active compounds | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1990-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170247399-A1 | PROCESS OF PRODUCING PHOSPHINOTHRICIN EMPLOYING NITRILASES | NPEPPS, NISCH, NAAA | GCLC 1631/4885GLUL 378/4885GRM8 3829/4885 |
| US-20150239917-A1 | Process of Producing Phosphinothricin Employing Nitrilases | NPEPPS, NISCH, NAAA | GCLC 1631/4885GLUL 378/4885GRM8 3829/4885 |
| US-20130204031-A1 | PROCESS OF PRODUCING PHOSPHINOTHRICIN EMPLOYING NITRILASES | NPEPPS, NISCH, NAAA | GCLC 1631/4885GLUL 378/4885GRM8 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.